Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Rosa

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2009
Oral poly(ADP-ribose) polymerase-1 inhibitor BSI-401 has antitumor activity and synergizes with oxaliplatin against pancreatic cancer, preventing acute neurotoxicityDavide Melisi, Valeria Ossovskaya, Cihui Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2011
Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancersRoberta Rosa, Davide Melisi, Vincenzo Damiano, et al.
Carcinogenesis|June 7, 2011
Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}BMarco Tafani, Luana Schito, Laura Pellegrini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
A novel toll-like receptor 9 agonist cooperates with trastuzumab in trastuzumab-resistant breast tumors through multiple mechanisms of actionVincenzo Damiano, Sonia Garofalo, Roberta Rosa, et al.
Journal of Cellular Physiology|January 30, 2013
SIRT1 silencing confers neuroprotection through IGF-1 pathway activationLuigi Sansone, Valentina Reali, Laura Pellegrini, et al.
Proteomics|January 3, 2013
Increased anaerobic metabolism is a distinctive signature in a colorectal cancer cellular model of resistance to antiepidermal growth factor receptor antibodyFrancesca Monteleone, Roberta Rosa, Monica Vitale, et al.
Journal of Fish Diseases|July 2, 2024
Changes in blood serum parameters in farmed rainbow trout (Oncorhynchus mykiss) during a piscine lactococcosis outbreakGiuseppe Esposito, Stefania Bergagna, Silvia Colussi, et al.
Plos Neglected Tropical Diseases|November 27, 2013
Isolation of saint louis encephalitis virus from a horse with neurological disease in BrazilRoberta Rosa, Erica Azevedo Costa, Rafael Elias Marques, et al.
Scientific Reports|March 4, 2017
Complete mitochondrial sequences from Mesolithic SardiniaAlessandra Modi, Francesca Tassi, Roberta Rosa Susca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2008
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cellsRoberto Bianco, Roberta Rosa, Vincenzo Damiano, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2009
Oral poly(ADP-ribose) polymerase-1 inhibitor BSI-401 has antitumor activity and synergizes with oxaliplatin against pancreatic cancer, preventing acute neurotoxicityDavide Melisi, Valeria Ossovskaya, Cihui Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2011
Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancersRoberta Rosa, Davide Melisi, Vincenzo Damiano, et al.
Carcinogenesis|June 7, 2011
Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}BMarco Tafani, Luana Schito, Laura Pellegrini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
A novel toll-like receptor 9 agonist cooperates with trastuzumab in trastuzumab-resistant breast tumors through multiple mechanisms of actionVincenzo Damiano, Sonia Garofalo, Roberta Rosa, et al.
Journal of Cellular Physiology|January 30, 2013
SIRT1 silencing confers neuroprotection through IGF-1 pathway activationLuigi Sansone, Valentina Reali, Laura Pellegrini, et al.
Proteomics|January 3, 2013
Increased anaerobic metabolism is a distinctive signature in a colorectal cancer cellular model of resistance to antiepidermal growth factor receptor antibodyFrancesca Monteleone, Roberta Rosa, Monica Vitale, et al.
Journal of Fish Diseases|July 2, 2024
Changes in blood serum parameters in farmed rainbow trout (Oncorhynchus mykiss) during a piscine lactococcosis outbreakGiuseppe Esposito, Stefania Bergagna, Silvia Colussi, et al.
Plos Neglected Tropical Diseases|November 27, 2013
Isolation of saint louis encephalitis virus from a horse with neurological disease in BrazilRoberta Rosa, Erica Azevedo Costa, Rafael Elias Marques, et al.
Scientific Reports|March 4, 2017
Complete mitochondrial sequences from Mesolithic SardiniaAlessandra Modi, Francesca Tassi, Roberta Rosa Susca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2008
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cellsRoberto Bianco, Roberta Rosa, Vincenzo Damiano, et al.
Pageof 5